SPARC NEWS why is Sun Pharma Advanced Research Company Limited price falling or rising
SPARC NEWS reasons for why stock price of Sun Pharma Advanced Research Company Limited is falling or rising
SPARC Sun Pharma is falling or rising technical reasons
Technical analysis forecast of Sun Pharma Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Sun Pharma SPARC at this time. Stock is rising and might rise more.
It appears as if Sun Pharma SPARC gave a large move recently.
Stock of Sun Pharma (SPARC) is trading above an important moving average line, and it has been above this line for quite some time now. This is a good sign, and the stock might keep rising and move higher!
My analysis of Sun Pharma is bullish for shortterm, but trade for tomorrow is selective. Take a BUY trade only if Sun Pharma stays above 147.4, but if it comes below 147.4, then a intra day sell could be more profitable.
If you take a sell trade below 147.4, then use 147.4 as stoploss and 139.25 as target. However if you take a buy trade in Sun Pharma, then use 147.4 as stoploss and 157.3 as target.
SPARC Sun Pharma is falling or rising NEWS fundamental reasons
Sun Pharma Advanced Research jumps 11%, extends 2-day rally as US court clears Sezaby PRV Sun Pharma Advanced Research Company surged for a second straight session after a U.S. court ruled in its favour on the Sezaby Priority Review Voucher. The stock jumped over 11%, extending Tuesday’s 20% rally, even as analysts caution about overbought tech - NEWS as on 2025-12-03 indiatimes.com
Company Announcement Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated December 02, 2025, titled "Press Release about U.S. District Court Grants Summary Judgement in Favour of SPARC for Sezaby PRV". - NEWS as on 2025-12-02
Sun Pharma brings global psoriasis drug ILUMYA to Indian market Sun Pharmaceutical Industries has launched its innovative biologic drug, ILUMYA, in India for moderate-to-severe plaque psoriasis. This novel treatment, Tildrakizumab, has a proven track record globally for providing significant and sustained skin clearanc - NEWS as on 2025-12-01 indiatimes.com
Sun Pharma launches Ilumya for psoriasis treatment in India Sun Pharmaceutical Industries has launched its innovative drug Ilumya in India. This medication treats moderate-to-severe plaque psoriasis. Clinical studies in India showed significant skin clearance in patients. Ilumya offers a new treatment option for th - NEWS as on 2025-12-01 indiatimes.com
Missed Sun Pharma’s rally? Trend pause offers fresh buying chance, Ajit Mishra - NEWS as on 2025-11-27 indiatimes.com
Company Announcement Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated November 20, 2025, titled "SPARC announces Complete Response Letter Resubmission for PDP-716 NDA by Ocuvex". - NEWS as on 2025-11-20
Company Announcement Sun Pharma Advanced Research Company Limited has informed the Exchange about Copy of Newspaper Publication - NEWS as on 2025-11-12
Company Announcement Sun Pharma Advanced Research Company Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025. - NEWS as on 2025-11-11
Company Announcement - NEWS as on 2025-10-31
Company Announcement Sun Pharma Advanced Research Company Limited has informed the Exchange about Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 - NEWS as on 2025-10-09
Company Announcement Sun Pharma Advanced Research Company Limited has informed the Exchange regarding Proceedings including Chairman Speech of Annual General Meeting held on August 12, 2025 - NEWS as on 2025-08-13
Company Announcement Sun Pharma Advanced Research Company Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025. - NEWS as on 2025-08-04
Board Meeting to discuss Financial Results To consider and approve the financial results for the period ended Jun 30, 2025 - NEWS as on 2025-07-29
Company Announcement Sun Pharma Advanced Research Company Limited has informed the Exchange about Copy of Newspaper Publication of 20th Annual General Meeting of the Company - NEWS as on 2025-07-10
Company Announcement Sun Pharma Advanced Research Company Limited has informed the Exchange regarding 'Intimation of the 20th Annual General Meeting of the Company'. - NEWS as on 2025-07-08
Company Announcement Sun Pharma Advanced Research Company Limited has informed the Exchange about incorporation of wholly owned subsidiary company - NEWS as on 2025-07-07
More announcements and NEWS
SPARC Sun Pharma Advanced Research Company Limited current price & indicator signals
Recent prices of SPARC Sun Pharma Advanced Research Company Limited are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 04 Thu Dec 2025 | 152.10 | 146.94 to 159.95 | 0.36% | 4.07 times |
| 03 Wed Dec 2025 | 151.55 | 149.65 to 179.43 | -5.88% | 7.95 times |
| 02 Tue Dec 2025 | 161.02 | 134.19 to 161.02 | 19.99% | 1.71 times |
| 01 Mon Dec 2025 | 134.19 | 133.30 to 135.48 | -0.24% | 0.01 times |
| 28 Fri Nov 2025 | 134.51 | 133.41 to 137.43 | -0.84% | 0.01 times |
| 27 Thu Nov 2025 | 135.65 | 132.30 to 136.91 | 1.43% | 0.01 times |
| 26 Wed Nov 2025 | 133.74 | 132.30 to 135.83 | 0.69% | 0.02 times |
| 25 Tue Nov 2025 | 132.83 | 131.81 to 133.99 | -0.51% | 0.02 times |
| 24 Mon Nov 2025 | 133.51 | 132.20 to 137.56 | -1.84% | 0.03 times |
| 21 Fri Nov 2025 | 136.01 | 134.54 to 145.37 | -1.48% | 0.14 times |
| 20 Thu Nov 2025 | 138.06 | 129.00 to 140.68 | 5.62% | 0.1 times |
| 19 Wed Nov 2025 | 130.72 | 128.11 to 131.30 | 0.45% | 0.01 times |
Videos related to: SPARC NEWS why is Sun Pharma Advanced Research Company Limited price falling or rising
Hindi Video What Is Needed To Succeed In Stock Markets
Hindi Basics How To Trade In FnO Futures Options Stock Market
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance


